GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q4 2022

SEC EDGAR SourceSEC Filings

Top Holdings53 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

THE CIGNA GROUP

1.8M$609.6M13.5%$209.33+49.85%
17 qtrssince 2018-Q4
Decreased
0

TENET HEALTHCARE CORP

8.9M$434M9.6%$27.66+76.41%
17 qtrssince 2018-Q4
Increased
67
SPYSPY
PUT

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

718,900$274.9M6.1%
New

DXC TECHNOLOGY CO

9.7M$257.2M5.7%$38.82-31.73%
17 qtrssince 2018-Q4
Increased
60

FISERV INC

2.5M$255M5.7%$103.02-1.89%
14 qtrssince 2019-Q3
Decreased
0

MCKESSON CORP

650,643$244.1M5.4%$144.46+155.90%
17 qtrssince 2018-Q4
Decreased
0

GLOBAL PAYMENTS INC

2.4M$237.5M5.3%$150.66-36.01%
9 qtrssince 2020-Q4
Increased
66

US FOODS HOLDING CORP

3.8M$130.8M2.9%$36.59-7.02%
5 qtrssince 2021-Q4
Decreased
0

UNIVERSAL HEALTH SERVICES-B

905,748$127.6M2.8%$138.920.00%
1 qtr
New
78

COCA-COLA EUROPACIFIC PARTNE

2.1M$114.5M2.5%$47.04+7.98%
8 qtrssince 2021-Q1
Increased
52

VALVOLINE INC

3.5M$114.1M2.5%$28.92+12.91%
4 qtrssince 2022-Q1
Increased
53

HCA HOLDINGS INC

439,985$105.6M2.3%$151.59+54.48%
17 qtrssince 2018-Q4
Increased
68

BAXTER INTERNATIONAL INC

2M$102.4M2.3%$73.70-35.87%
12 qtrssince 2020-Q1
Decreased
0

UBER TECHNOLOGIES INC

4M$99M2.2%$40.30-38.63%
7 qtrssince 2021-Q2
Decreased
0

FMC CORP

721,996$90.1M2.0%$80.30+37.92%
17 qtrssince 2018-Q4
Decreased
0
4.1M$86.9M1.9%$13.36+21.00%
8 qtrssince 2021-Q1
Increased
57

APTIV PLC

921,271$85.8M1.9%$109.14-14.67%
9 qtrssince 2020-Q4
Decreased
0

CLARIVATE PLC

10.1M$84M1.9%$9.89-15.70%
3 qtrssince 2022-Q2
Increased
76

DUPONT DE NEMOURS INC

1.1M$78.6M1.7%$80.22+0.27%
9 qtrssince 2020-Q4
Decreased
0
ATVIATVIDelisted

ACTIVISION BLIZZARD INC

970,273$74.3M1.6%
5 qtrssince 2021-Q4
Increased
75
$4.5B
AUM
53
Positions
Q4 2022
Filing
Rating · 4.0
Quarterly Portfolio Change
-9%Q3'21$5.5B-15%Q4'21$4.7B+5%Q1'22$4.9B-19%Q2'22$4B+0%Q3'22$4B+13%Q4'22$4.5B
Activity profile
$ moved · Q4'22
New34%Increased25%Decreased23%Exited18%
Composition
Equity vs derivatives
Equity92%Puts6%Calls1%
Holding period
Avg 2.1 years
<1Q11%1-4Q19%1-2Y21%2Y+49%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $4.5B across 53 positions as of Q4 2022. Top holdings: CI (13.5%), THC (9.6%), SPY (6.1%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.

Q4 2022 Summary

Active quarter - 9 new positions, 11 exits, 19 increased. Top move: UHS (NEW, conviction 78). Portfolio: $4.5B across 53 positions.

Top holdings by portfolio weight

Total AUM$4B
CI13.51%
THC9.62%
DXC5.70%
FISV5.65%
MCK5.41%
GPN5.26%
USFD2.90%
UHS2.83%
CCEP2.54%
VVV2.53%
Other2.34%

Portfolio allocation by GICS sector

Sectors9
Healthcare41.67%
Technology15.83%
Industrials9.08%
Unknown8.91%
Consumer Cyclical8.75%
Basic Materials6.35%
Consumer Defensive5.88%
Communication Services2.27%
Financial Services1.27%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Technology
Compare DNA across all funds
7-dimension quality assessment
Strong(4.0 / 5.0)
Track Record72
Conviction49
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PAYMENTS INC
Q2 2025 Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAMAZON.COM INC
Q3 2025 Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used